<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_St_Andrews skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:St Andrews</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV style="position:absolute;top:5.5px;width:100%; "><DIV><NAV class="navbar navbar-inverse margins"><DIV class="container-fluid"><DIV class="collapse navbar-collapse" id="myNavbar"><UL class="nav navbar-nav "><LI class="active"><A href="https://2018.igem.org/Team:St_Andrews">Home</A></LI><LI class="dropdown"><A class="dropdown-toggle" data-toggle="dropdown" href="#">Team
              </A></LI><LI><A href="https://2018.igem.org/Team:St_Andrews/Team">Team members</A></LI><LI><A href="https://2018.igem.org/Team:St_Andrews/Collaborations">Collaborations</A></LI></UL><LI class="dropdown"><A class="dropdown-toggle" data-toggle="dropdown" href="#">Project
              </A></LI><LI><A href="https://2018.igem.org/Team:St_Andrews/Description">Description &amp; Design</A></LI><LI><A href="https://2018.igem.org/Team:St_Andrews/Experiments">Experiments</A></LI><LI><A href="https://2018.igem.org/Team:St_Andrews/Notebook">Notebook</A></LI><LI><A href="https://2018.igem.org/Team:St_Andrews/InterLab">InterLab</A></LI><LI><A href="https://2018.igem.org/Team:St_Andrews/Model">Model</A></LI><LI><A href="https://2018.igem.org/Team:St_Andrews/Results">Results</A></LI><LI><A href="https://2018.igem.org/Team:St_Andrews/Demonstrate">Demonstrate</A></LI><LI><A href="https://2018.igem.org/Team:St_Andrews/Improve">Improve</A></LI><LI><A href="https://2018.igem.org/Team:St_Andrews/Attributions">Attributions</A></LI><LI class="dropdown"><A class="dropdown-toggle" data-toggle="dropdown" href="#">Human practice
              </A></LI><LI><A href="https://2018.igem.org/Team:St_Andrews/Human_Practices">Human practices</A></LI><LI><A href="https://2018.igem.org/Team:St_Andrews/Public_Engagement">Education &amp; Engagement</A></LI><LI class="dropdown"><A href="https://2018.igem.org/Team:St_Andrews/Safety">Safety</A></LI><LI class="active"><A href="https://igem.org/2018_Judging_Form?team=St_Andrews">Judging form</A></LI></DIV></DIV></NAV><DIV class="header"><DIV class="col-sm-12"><DIV class="col-sm-7"><H1 style="font-size:7vmax; font-family: " trebuchet="" ms="">St Andrews iGEM 2018:</H1><H2 style="font-size:7vmax; font-family: " trebuchet="" ms=""><SPAN>metabo</SPAN><SPAN style="color: #1fff00">LIGHT</SPAN></H2></DIV></DIV><DIV class="col-sm-12"><DIV class="col-sm-1"><DIV class="scrolldwn"><H3><A id="arrow" style="font-size: 200%;color: white;">⤵</A></H3></DIV></DIV></DIV></DIV><DIV class="col-sm-12 "><P style="font-size:200%" id="destination">Project purpose</P><P style="font-size:120%">One of the growing threats to modern medicine is the resistance of bacteria to antibiotic substances.
  The increasing doses of antibiotics needed to clear infections have given way to entire strains of bacteria which are largely
  immune to the standard therapies. Our project centers around one way to combat this issue: that of developing new antibiotics
  altogether. Many bacteria engage in a kind of ‘germ warfare,’ releasing metabolites which are toxic to their competitors.
  Our aim is to create a screening system to determine which endogenous molecules within a bacterial sample perform this function, if any.
  In essence, we sought a way to assess the antimicrobial properties of any novel metabolites found in the course of metabolomic
  research.</P><P style="font-size:120%">Moreover, there are two ways in which a potential new lead compound for development into an antibiotic might be useful. First, it might be antibiotic in the classical sense--that it kills prokaryotes. Secondly, an antimicrobial substance might disrupt the formation of biofilms or the stability of extant ones. Biofilms are essentially the scaffolding around which a colony of bacteria live. They allow the members of the group to anchor to a surface, protect the bacteria from antibiotics, and trap food. Biofilm dependent infections are notoriously hard to clear, and consistently affect patients with conditions such as Cystic Fibrosis. If a metabolite were to disrupt a biofilm, then it too would have valuable properties not to overlook. As such, our project has two components: one to detect cell death, and another to detect the presence of biofilms.</P></DIV></DIV><DIV><DIV class="col-sm-12"><DIV class="col-sm-3"><P style="font-size:180%">Do you want to contact us? </P><P style="font-size:120%">Email: </P><P style="font-size:120%">igem2018@st-andrews.ac.uk </P></DIV><DIV class="col-sm-9"><P style="font-size:180%">Our sponsors: </P></DIV><DIV class="col-sm-3"><H4>Enhancement themes </H4><H4>University of St. Andrews : Proctor's Office </H4><H4>The genetic society</H4><H4>University of St. Andrews : School of Chemistry</H4></DIV><DIV class="col-sm-3"><H4>SULSA</H4><H4>University of St. Andrews : School of Biology</H4><H4> Wellcome Trust </H4><H4>University of St. Andrews : Physics</H4><H4>University of St. Andrews : Psychology and Neuroscience</H4></DIV><DIV class="col-sm-3"><H4>University of St. Andrews : Student Association  </H4><H4> CAPOD </H4><H4>University of St. Andrews : Computer Science</H4></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>